New insights into the cellular response to complex DNA damage induced by proton beam therapy

关于质子束治疗引起的复杂 DNA 损伤的细胞反应的新见解

基本信息

  • 批准号:
    MR/V028944/2
  • 负责人:
  • 金额:
    $ 38.39万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

Radiotherapy is still the most effective treatment for a number of human cancers, and the emergence of proton beam therapy (PBT) facilities in the UK, particularly in Manchester and London (operational from late 2018 and 2021, respectively), is likely to signal a new era for cancer treatment. This is due to the fact that PBT is a precision technique able to deliver the majority of the radiation dose directly to the cancer, thus sparing the surrounding normal tissues of any unwanted dose of radiation and reducing the adverse side-effects that are commonly observed with conventional radiotherapy. However whilst radiotherapy, including PBT, is known to act by causing damage to the DNA of cancer cells causing them to die, there is still not a complete understanding of the mechanisms which the cells use to repair certain types of DNA damage and that can cause significant resistance to treatment.This proposal therefore aims to reveal new knowledge into the basic biological mechanisms that cancer cells use to repair DNA damage caused by PBT, with the future goal of providing leads to the development of new strategies in combination with PBT for effective cancer treatment. Indeed, this study will largely employ cells derived from patients with head and neck cancer, which is a priority tumour research area within the University of Liverpool due to the high local incidence, but also a tumour which is increasingly being treated with PBT worldwide. Therefore, this proposal has the significant potential to devise future optimal treatments using PBT for head and neck cancer patients, leading to reductions in adverse side-effects and improvement in quality of life, but more importantly to increases in overall survival rates.
放射治疗仍然是许多人类癌症最有效的治疗方法,英国质子束治疗(PBT)设施的出现,特别是在曼彻斯特和伦敦(分别从2018年底和2021年开始运营),可能标志着癌症治疗的新时代。这是因为PBT是一种精确的技术,能够将大部分辐射剂量直接输送到癌症,从而使周围正常组织免受任何不必要的辐射剂量,并减少常规放射治疗中常见的不良副作用。然而,尽管已知包括PBT在内的放射疗法通过对癌细胞的DNA造成损伤而导致癌细胞死亡,对于细胞修复某些类型的DNA损伤的机制仍然没有完全的了解,并且可能导致对治疗的显着抵抗。因此,该提案旨在揭示癌细胞修复DNA损伤的基本生物学机制的新知识。PBT,未来的目标是为开发与PBT相结合的新策略提供线索,以有效治疗癌症。事实上,这项研究将主要采用来自头颈癌患者的细胞,由于当地发病率高,头颈癌是利物浦大学的优先肿瘤研究领域,但也是一种越来越多地用PBT治疗的肿瘤。因此,该提案具有设计未来使用PBT治疗头颈癌患者的最佳治疗的巨大潜力,从而减少不良副作用并改善生活质量,但更重要的是提高总生存率。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
DNA damage and repair dependencies of ionising radiation modalities.
  • DOI:
    10.1042/bsr20222586
  • 发表时间:
    2023-10-31
  • 期刊:
  • 影响因子:
    4
  • 作者:
  • 通讯作者:
The Cellular Response to Complex DNA Damage Induced by Ionising Radiation.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason Luke Parsons其他文献

The role of autophagy in hypoxia-induced radioresistance
自噬在低氧诱导的放射抗性中的作用
  • DOI:
    10.1016/j.radonc.2023.109951
  • 发表时间:
    2023-12-01
  • 期刊:
  • 影响因子:
    5.300
  • 作者:
    Rhianna Mae Hill;Matthew Fok;Gabrielle Grundy;Jason Luke Parsons;Sonia Rocha
  • 通讯作者:
    Sonia Rocha

Jason Luke Parsons的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason Luke Parsons', 18)}}的其他基金

New insights into the cellular response to complex DNA damage induced by proton beam therapy
关于质子束治疗引起的复杂 DNA 损伤的细胞反应的新见解
  • 批准号:
    MR/V028944/1
  • 财政年份:
    2021
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Research Grant
Advanced technologies for radiobiology and clinical radiotherapy
放射生物学和临床放射治疗的先进技术
  • 批准号:
    ST/T002158/1
  • 财政年份:
    2019
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Research Grant
The cellular response to complex DNA damage induced by ionising radiation
细胞对电离辐射引起的复杂 DNA 损伤的反应
  • 批准号:
    MR/M000354/1
  • 财政年份:
    2014
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Research Grant

相似国自然基金

Behavioral Insights on Cooperation in Social Dilemmas
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国优秀青年学者研究基金项目

相似海外基金

New insights into cultural differences in empathic concern and prosocial behavior: A cross-cultural study in Japan and the U.S.
对移情关注和亲社会行为的文化差异的新见解:日本和美国的跨文化研究
  • 批准号:
    24K16787
  • 财政年份:
    2024
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
New insights into female reproductive tract formation and tubulogenesis.
对女性生殖道形成和肾小管发生的新见解。
  • 批准号:
    DP240100491
  • 财政年份:
    2024
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Discovery Projects
Harnessing the interplay of genetics, cells, and matrix, to deliver insights into musculoskeletal health and new therapies in musculoskeletal disease
利用遗传学、细胞和基质的相互作用,深入了解肌肉骨骼健康和肌肉骨骼疾病的新疗法
  • 批准号:
    MR/Y030419/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Research Grant
Conference: 2023 Staphylococcal Diseases GRC and GRS: New Insights into Staphylococcal Biology, Disease Mechanisms and Treatment
会议:2023 年葡萄球菌疾病 GRC 和 GRS:对葡萄球菌生物学、疾病机制和治疗的新见解
  • 批准号:
    2334757
  • 财政年份:
    2023
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Standard Grant
New insights into how the brain interprets visceral and somatic sensations
关于大脑如何解释内脏和躯体感觉的新见解
  • 批准号:
    DE230101079
  • 财政年份:
    2023
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Discovery Early Career Researcher Award
New insights into the development of metabolic dysfunction as a comorbidity in Crohn's disease.
关于代谢功能障碍作为克罗恩病合并症的发展的新见解。
  • 批准号:
    493720
  • 财政年份:
    2023
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Operating Grants
New insights into extracellular signal transduction
细胞外信号转导的新见解
  • 批准号:
    10566506
  • 财政年份:
    2023
  • 资助金额:
    $ 38.39万
  • 项目类别:
Hiding the enemy within: gaining new insights into HIV integration and the establishment and maintenance of latency.
将敌人隐藏在内部:获得对艾滋病毒整合以及潜伏期的建立和维持的新见解。
  • 批准号:
    493467
  • 财政年份:
    2023
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Operating Grants
New insights into impact chemistry through light gas gun integrated in situ mass spectrometry
通过集成原位质谱分析的轻气枪对冲击化学的新见解
  • 批准号:
    ST/W005549/1
  • 财政年份:
    2022
  • 资助金额:
    $ 38.39万
  • 项目类别:
    Research Grant
New insights into early T cell protection during acute toxoplasmosis
急性弓形虫病期间早期 T 细胞保护的新见解
  • 批准号:
    10633247
  • 财政年份:
    2022
  • 资助金额:
    $ 38.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了